ES2078733T3 - Metodo para la deteccion de anticuerpos anti-arn. - Google Patents

Metodo para la deteccion de anticuerpos anti-arn.

Info

Publication number
ES2078733T3
ES2078733T3 ES92902145T ES92902145T ES2078733T3 ES 2078733 T3 ES2078733 T3 ES 2078733T3 ES 92902145 T ES92902145 T ES 92902145T ES 92902145 T ES92902145 T ES 92902145T ES 2078733 T3 ES2078733 T3 ES 2078733T3
Authority
ES
Spain
Prior art keywords
pct
date sep
detection
sec
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92902145T
Other languages
English (en)
Inventor
Venrooij Walther Jacobus Van
Rene Antonius Hoet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2078733T3 publication Critical patent/ES2078733T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PRESENTA UN METODO PARA LA DETECCION Y DETERMINACION CUANTITATIVA DE ANTICUERPOS ANTI-RNA EN UN FLUIDO DE PRUEBA DE PACIENTES CON UNA ENFERMEDAD AUTOINMUNE MEDIANTE LA PUESTA EN CONTACTO DEL RNA CON EL FLUIDO DE PRUEBA MEDIANTE LO CUAL SE PRODUCE UNA REACCION ENTRE EL RNA Y LOS ANTICUERPOS ANTI-RNA PRESENTES EN EL FLUIDO DE PRUEBA DESPUES DE LO CUAL UNA DETERMINACION CUALITATIVA Y/O CUANTITATIVA DE LOS ANTICUERPOS QUE REACCIONAN CON EL RNA SUMINISTRA INFORMACION SOBRE EL CURSO DE LA ENFERMEDAD.
ES92902145T 1991-01-22 1992-01-16 Metodo para la deteccion de anticuerpos anti-arn. Expired - Lifetime ES2078733T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200121 1991-01-22

Publications (1)

Publication Number Publication Date
ES2078733T3 true ES2078733T3 (es) 1995-12-16

Family

ID=8207502

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92902145T Expired - Lifetime ES2078733T3 (es) 1991-01-22 1992-01-16 Metodo para la deteccion de anticuerpos anti-arn.

Country Status (15)

Country Link
US (1) US5385824A (es)
EP (1) EP0568554B1 (es)
JP (1) JP3288041B2 (es)
KR (1) KR100244799B1 (es)
AT (1) ATE126599T1 (es)
AU (1) AU658860B2 (es)
CA (1) CA2101166C (es)
DE (1) DE69204157T2 (es)
DK (1) DK0568554T3 (es)
ES (1) ES2078733T3 (es)
FI (1) FI107359B (es)
GR (1) GR3017975T3 (es)
IE (1) IE66750B1 (es)
WO (1) WO1992013276A1 (es)
ZA (1) ZA92389B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576186A (en) * 1994-09-01 1996-11-19 The University Of Kansas Diagnosis and monitoring of rheumatological diseases by detection of anti-EF1-α antibodies
EP1334113A4 (en) * 2000-10-20 2007-08-08 Expression Diagnostics Inc EVALUATION OF LEUCOCYTAIRE EXPRESSION LEVEL
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) * 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
WO2006029184A2 (en) * 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
EP1885889A4 (en) * 2005-05-11 2010-01-20 Expression Diagnostics Inc METHOD FOR MONITORING THE OPERATING STATUS OF TRANSPLANTS OVER GENLISTS
AU2007309726A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
US7993832B2 (en) * 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
WO2008140484A2 (en) * 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2012068107A2 (en) * 2010-11-17 2012-05-24 University Of Florida Research Foundation, Inc. Autoantibody to rna-protein complex detected by quantitative pcr
US20170044591A1 (en) * 2014-04-24 2017-02-16 Alnylam Pharmaceuticals, Inc. Methods and compositions for detecting anti-drug antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784942A (en) * 1984-11-05 1988-11-15 The Board Of Regents For The University Of Oklahoma Monoclonal antibodies against autoimmune RNA proteins
CA2050340A1 (en) * 1989-02-27 1990-08-28 Corgenix, Inc. Method and diagnostic test kit for detection of autoimmune antibody

Also Published As

Publication number Publication date
FI933291A0 (fi) 1993-07-21
CA2101166A1 (en) 1992-07-23
DE69204157T2 (de) 1996-03-21
EP0568554B1 (en) 1995-08-16
KR100244799B1 (ko) 2000-03-02
FI933291A (fi) 1993-08-18
DK0568554T3 (da) 1995-12-04
ZA92389B (en) 1992-09-30
KR930703612A (ko) 1993-11-30
AU658860B2 (en) 1995-05-04
EP0568554A1 (en) 1993-11-10
AU1161592A (en) 1992-08-27
IE920132A1 (en) 1992-07-29
GR3017975T3 (en) 1996-02-29
ATE126599T1 (de) 1995-09-15
US5385824A (en) 1995-01-31
WO1992013276A1 (en) 1992-08-06
IE66750B1 (en) 1996-02-07
JPH06504620A (ja) 1994-05-26
DE69204157D1 (de) 1995-09-21
FI107359B (fi) 2001-07-13
JP3288041B2 (ja) 2002-06-04
CA2101166C (en) 2003-05-20

Similar Documents

Publication Publication Date Title
ES2078733T3 (es) Metodo para la deteccion de anticuerpos anti-arn.
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
EP1099102A4 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
DE69033796D1 (de) Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten
DE69230890D1 (de) Bestimmung von nukleären matrixproteinen in flüssigkeiten
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
IT206959Z2 (it) Dispositivo usa e getta per la raccolta di campioni fisiologici, in particolare campioni corpologici.
ATE178357T1 (de) Nachweismethoden für c-raf-1-genes.5
ES2093277T3 (es) Metodo para la deteccion de daño epitelial gastrico.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
AU5336796A (en) Method for detecting allergy
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
ATE130099T1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.
NO883288D0 (no) Anordning for bestemmelse av blod.
RU94014977A (ru) Способ оценки уровня серонина в цельной крови
Forbes The haemophilias: clinical and laboratory investigations
IT1216742B (it) Dispositivo e procedimento per la realizzazione estemporanea di testdiagnostici quantitativi sul sangue intero.
Larsen et al. Epidemiological Studies of Multiple Sclerosis in Western Norway: Possible Factors in Etiology and Prognosis
UA6640A (uk) Спосіб прогнозування загострення супутнього захворювання при активізації основної патології
UA34212A (uk) Спосіб оцінки результатів лікування хворих на ранні форми сифілісу
IT8221232V0 (it) Dispositivo di lettura, particolarmente utile per persone anziane, musicisti, ammalati, handicappati e simili.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 568554

Country of ref document: ES